JNJ (Johnson & Johnson) Days Inventory: 161.96 (As of Mar. 2026) — 14% Above Median


JNJ Johnson & Johnson JNJ
85 GF Score
Price $261.31
GF Value $190.78
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Johnson & Johnson Days Inventory?

Johnson & Johnson JNJ +2.88% 85 Days Inventory is 161.96 as of Mar. 2026, which is 14% above its 10-year median of 141.54. GuruFocus rates JNJ with a GF Score™ of 85/100 and a GF Value™ of $190.78 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 918 Drug Manufacturers companies, Johnson & Johnson ranks better than 50.33% on this metric.

Days Inventory is also known as Days Sales of Inventory (DSI). Johnson & Johnson's Average Total Inventories for the three months ended in Mar. 2026 was $14,387 Mil. Johnson & Johnson's Cost of Goods Sold for the three months ended in Mar. 2026 was $8,106 Mil. Hence, Johnson & Johnson's Days Inventory for the three months ended in Mar. 2026 was 161.96.

The historical rank and industry rank for Johnson & Johnson's Days Inventory or its related term are showing as below:

JNJ' s Days Inventory Range Over the Past 10 Years
Min: 116.69   Med: 141.54   Max: 162.44
Current: 162.44

During the past 13 years, Johnson & Johnson's highest Days Inventory was 162.44. The lowest was 116.69. And the median was 141.54.

JNJ's Days Inventory is ranked better than
50.33% of 918 companies
in the Drug Manufacturers industry
Industry Median: 164.43 vs JNJ: 162.44

Johnson & Johnson's Days Inventory increased from Mar. 2025 (155.68) to Mar. 2026 (161.96). It might indicate that Johnson & Johnson's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Johnson & Johnson's Inventory Turnover for the three months ended in Mar. 2026 was 0.56.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Johnson & Johnson's Inventory-to-Revenue for the three months ended in Mar. 2026 was 0.60.


Johnson & Johnson  (NYSE:JNJ) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Johnson & Johnson's Inventory Turnover for the three months ended in Mar. 2026 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Johnson & Johnson's Inventory to Revenue for the three months ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Johnson & Johnson Days Inventory Related Terms


Johnson & Johnson Days Inventory Historical Data

* Premium members only.

The historical data trend for Johnson & Johnson's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Johnson & Johnson Days Inventory Chart

Johnson & Johnson Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 153.87 153.26 147.42 156.95 160.66

Johnson & Johnson Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 155.68 155.94 172.17 162.26 161.96

JNJ vs ABBV, MRK, AMGN: Days Inventory Comparison

For the Drug Manufacturers - General subindustry, Johnson & Johnson's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Johnson & Johnson Days Inventory vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Days Inventory distribution charts can be found below:

* The bar in red indicates where Johnson & Johnson's Days Inventory falls into.


JNJ
85GF Score
Johnson & Johnson JNJ
Days Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Johnson & Johnson Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Johnson & Johnson's Days Inventory for the fiscal year that ended in Dec. 2025 is calculated as

Days Inventory (A: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2024 ) + Total Inventories (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (12444 + 14191) / 2 ) / 30256*365
=13317.5 / 30256*365
=160.66

Johnson & Johnson's Days Inventory for the quarter that ended in Mar. 2026 is calculated as:

Days Inventory (Q: Mar. 2026 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Dec. 2025 ) + Total Inventories (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (14191 + 14583) / 2 ) / 8106*365 / 4
=14387 / 8106*365 / 4
=161.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Inventory →
What does a Days Inventory of 161.96 mean?
Johnson & Johnson (JNJ) has a Days Inventory of 161.96 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Johnson & Johnson and its competitors. This is 14% above median its historical median of 141.54. Over the past decade, Johnson & Johnson's Days Inventory has ranged from 116.69 to 162.44. According to the industry distribution chart, Johnson & Johnson ranks #456 out of 918 companies in the Drug Manufacturers industry, placing it in the top 49.7%.
Is Johnson & Johnson's Days Inventory too high?
Johnson & Johnson's current Days Inventory of 161.96 is 14% above median its 10-year median of 141.54. Over the past 10 years, this metric has ranged from a low of 116.69 to a high of 162.44. The Drug Manufacturers industry median Days Inventory is 164.43. Johnson & Johnson's value of 161.96 is 1.5% below this industry median. Based on the distribution chart, Johnson & Johnson ranks #456 out of 918 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Johnson & Johnson has a GF Score™ of 85/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Johnson & Johnson's Days Inventory compare to ABBV and MRK?
According to the Drug Manufacturers industry distribution chart, Johnson & Johnson ranks #456 out of 918 companies for Days Inventory. This puts Johnson & Johnson in the upper half of its industry. The industry median Days Inventory is 164.43. Johnson & Johnson's value of 161.96 is 1.5% below this benchmark. Historically, Johnson & Johnson's own Days Inventory has ranged from 116.69 to 162.44 over the past decade. While the company's 10-year median is 141.54 vs. the industry median of 164.43, Johnson & Johnson has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 918 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Johnson & Johnson's current Days Inventory of 161.96 is 1.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Johnson & Johnson and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Johnson & Johnson's current Days Inventory is 161.96, which is 14% above median its own 10-year median of 141.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Johnson & Johnson stock overvalued right now?
Based on GuruFocus' analysis, Johnson & Johnson (JNJ) is currently considered Significantly Overvalued. The stock's GF Value™ is $190.78, compared to a current price of $261.31 — trading 37% above its estimated fair value. The current Days Inventory is 161.96, which is 14% above median its 10-year median of 141.54 and 1.5% below the Drug Manufacturers industry median of 164.43. Johnson & Johnson's overall GF Score™ is 85/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Johnson & Johnson (JNJ), the current Days Inventory is 161.96 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Johnson & Johnson (JNJ) Overvalued in 2026?

Based on GuruFocus' analysis, Johnson & Johnson stock appears to be overvalued. The current stock price of $261.31 is trading 37% above its estimated GF Value™ of $190.78. GuruFocus considers Johnson & Johnson to be Significantly Overvalued.

Key valuation signals for JNJ:

  • Days Inventory: 161.96 (14% above median its 10-year median of 141.54)
  • GF Value™: $190.78 vs. price of $261.31 (37% above fair value)
  • GF Score™: 85/100 with 7 warning signs
  • Industry Position: 1.5% below the Drug Manufacturers median (#456 of 918)

No single metric tells the full story. See the JNJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Johnson & Johnson Business Description

Address One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
85GF Score

Get the complete analysis for JNJ

Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$261.31
Price
$190.78
GF Value